Comparison of ACT and CBSM for Caregivers in Cancer
Comparing the Effectiveness of Acceptance and Commitment Therapy and Cognitive Behavioral Stress Management on Fear of Recurrence, Quality of Life, Psychological Distress, and Fatigue of Caregivers of Cancer Patients
1 other identifier
interventional
66
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effectiveness of cognitive-behavioral stress management (CBSM) and acceptance and commitment therapy (ACT) on the fear of recurrence, quality of life, psychological distress, and fatigue of caregivers of cancer patients. Researchers compare the effectiveness of CBSM and ACT to a Control(without receiving intervention) to see if treatment works to improve the health of caregivers of cancer patients. A comparison between the two treatments was also conducted to determine if there was a difference in their effectiveness. Participants: In this study, 66 participants were randomly assigned to one of three groups: the CBSM group, the ACT group, or the control group. The CBSM and ACT groups each attended eight 90-minute, in-person sessions twice a week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2024
CompletedFirst Submitted
Initial submission to the registry
December 29, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
December 1, 2025
28 days
December 29, 2025
December 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fear of Cancer Recurrence Inventory-caregiver (FCRI-c)
This scale, developed by Lin et al., (2018), consists of 42 items measured on a 5-point Likert scale, encompassing seven subscales related to triggers, severity, psychological distress, functional impairment, insight, reassurance, and coping Strategy.
assessments at three distinct time points: at baseline (pre-intervention), immediately following the four-week intervention period (post-test), and at a two-month follow-up.
Depression Anxiety and Stress (DASS)
This scale, developed by Lovibond and Lovibond (1995), consists of 21 items measured on a 4-point Likert scale, encompassing three subscales for depression, anxiety, and stress.
assessments at three distinct time points: at baseline (pre-intervention), immediately following the four-week intervention period (post-test), and at a two-month follow-up.
Caregiver Quality of Life-Cancer (CQOLC)
This scale, developed by Weitzner et al., (1999), consists of 35 items measured on a 5-point Likert scale, encompassing four subscales for burden, disruptiveness, positive adaptation, and financial concern, along with eight additional items.
assessments at three distinct time points: at baseline (pre-intervention), immediately following the four-week intervention period (post-test), and at a two-month follow-up.
Multidimensional Fatigue Inventory (MFI)
This scale, developed by Smets et al., (1995), consists of 20 items measured on a 5-point Likert scale, encompassing five subscales: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue.
assessments at three distinct time points: at baseline (pre-intervention), immediately following the four-week intervention period (post-test), and at a two-month follow-up.
Study Arms (3)
Cognitive Behavioral Stress Management (CBSM)
EXPERIMENTALParticipants in this group receive Cognitive Behavioral Stress Management (CBSM)
Acceptance and Commitment Therapy (ACT)
EXPERIMENTALParticipants in this group receive Acceptance and Commitment Therapy (ACT)
Control
NO INTERVENTIONThe control group receives no intervention.
Interventions
consisted of eight in-person sessions, twice a week for 90 minutes each
consisted of eight in-person sessions, twice a week for 90 minutes each
Eligibility Criteria
You may qualify if:
- To be included in the study, caregivers had to be 18 years or older, literate, and provide informed consent. A key requirement was that participants either lived with the patient or visited them at least twice a week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emdadgaran-e Ashura Charity Institute
Yazd, Yazd Province, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Msc Psychology
Study Record Dates
First Submitted
December 29, 2025
First Posted
January 9, 2026
Study Start
June 24, 2024
Primary Completion
July 22, 2024
Study Completion
September 22, 2024
Last Updated
January 9, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share